NASDAQ:KPRX | Free Cash Flow | KIORA PHARMACEUTICALS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.16M$5,018.00-$3.17M
2025-12-31-$2.18M$78,163.00-$2.26M
2025-03-31-$2.7M$0.00-$2.7M
2024-12-31-$2.25M-$45,031.00-$2.3M
2024-03-31$13.62M
2023-12-31-$2.58M$0.00-$2.58M
2023-03-31-$3.07M
2022-12-31-$2.13M
2022-03-31-$2.83M
2021-12-31-$2.92M$0.00-$2.92M
2021-03-31-$2.57M$58,119.00-$2.63M
2020-12-31-$1.71M
2020-03-31-$2.4M
2019-12-31-$2.59M$0.00-$2.59M
2019-03-31-$2.15M
2018-12-31-$2M$0.00-$2M
2018-03-31-$4.11M
2017-12-31-$1.45M$36,999.00-$1.49M
2017-03-31-$18,601.00
2016-12-31-$2.05M
2016-03-31-$1.35M
2015-12-31-$1.55M
2015-03-31-$1.77M
2014-12-31-$436,135.00
2014-03-31-$431,098.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.96M$110,789.00-$10.07M
2024-12-31$8.56M$6,256.00$8.55M237.93%
2023-12-31-$9.56M$0.00-$9.56M
2022-12-31-$10.43M$0.00-$10.43M
2021-12-31-$10.68M$63,865.00-$10.74M
2020-12-31-$7.32M$20,077.00-$7.34M
2019-12-31-$8.15M$0.00-$8.15M
2018-12-31-$10.84M$20,000.00-$10.86M
2017-12-31-$6.47M$36,999.00-$6.51M
2016-12-31-$8.41M$0.00-$8.41M
2015-12-31-$4.46M
2014-12-31-$950,617.00